CJC-1295 No-DAC vs CJC-1295 with DAC — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
CJC-1295 No-DAC (also called Modified GRF 1-29 or Mod GRF) is a short-acting GHRH (Growth Hormone-Releasing Hormone) analog consisting of the first 29 amino acids of endogenous GHRH with four amino acid substitutions to improve stability and receptor binding....
Calculate CJC-1295 No-DAC dose →CJC-1295 with DAC is a long-acting GHRH analog that uses a Drug Affinity Complex (DAC) technology - a reactive maleimidoproprionic acid linker that covalently bonds to plasma albumin after injection. This albumin binding dramatically extends its half-life to 6-8 days, allowing on...
Calculate CJC-1295 with DAC dose →| Parameter | CJC-1295 No-DAC | CJC-1295 with DAC |
|---|---|---|
| Category | Growth Hormone & IGF | Growth Hormone & IGF |
| Research | Research Use | Research Use |
| Half-Life | 30 minutes | 6–8 days |
| Typical Dose | 100–200 µg | 1,000–2,000 µg |
| Frequency | 2–3x daily | Once or twice weekly |
| Route | Subcutaneous | Subcutaneous |
| FDA Status | Not Approved | Not Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.